Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 12/2014

01-11-2014 | Melanomas

Primary Melanoma Location on the Scalp is an Important Risk Factor for Brain Metastasis: A Study of 1,687 Patients with Cutaneous Head and Neck Melanomas

Authors: Anna M. Huismans, MD, Lauren E. Haydu, BSCHE, MIPH, Kerwin F. Shannon, MBBS, Michael J. Quinn, MBBS, Robyn P. M. Saw, MS, Andrew J. Spillane, MD, Jonathan R. Stretch, MBBS, DPhil, John F. Thompson, MD

Published in: Annals of Surgical Oncology | Issue 12/2014

Login to get access

Abstract

Background

Primary cutaneous head and neck melanomas (HNM) are reported to be associated with a higher incidence of brain metastasis than trunk and limb melanomas (TLM). In this study, the incidence of brain metastases in patients with HNM and risk factors for the development of brain metastases were analyzed.

Methods

From a large, prospectively-collected database, 1,687 HNM patients and 8,793 TLM patients who presented with American Joint Committee on Cancer (AJCC) stage I and II disease were identified. Survival was assessed using the Kaplan–Meier method and multivariate Cox regression analysis. Independent risk factors were determined by binary logistic regression analysis.

Results

The incidence of brain metastases 5 years after diagnosis of HNM was 6.7 % compared with 4.7 % for brain metastases from TLM (p = 0.003). Patients with scalp melanomas were most likely to develop brain metastases (12.7 %). Independent risk factors for brain metastasis in patients with HNM were Breslow thickness, ulceration, and scalp location.

Conclusion

Patients with primary scalp melanomas had a much higher incidence of brain metastasis than patients with melanomas on other head and neck sites, who in turn had a higher incidence than patients with melanomas on sites elsewhere on the body. More intensive monitoring of patients with scalp melanomas, who are at particularly high risk of brain metastasis, might lead to earlier discovery of metastatic disease in the brain, offering the prospect of earlier intervention and better outcomes.
Literature
1.
Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the surveillance, epidemiology, and end results (SEER) program. Arch Dermatol. 2008;144:515–21.PubMed
2.
Law MM, Wong JH. Evaluation of the prognostic significance of the site of origin of cutaneous melanoma. Am Surg. 1994;60:362–6.PubMed
3.
Urist MM, Balch CM, Soong SJ, et al. Head and neck melanoma in 534 clinical Stage I patients: a prognostic factors analysis and results of surgical treatment. Ann Surg. 1984;200:769–75.PubMedCrossRefPubMedCentral
4.
Zakrzewski J, Geraghty LN, Rose AE, Christos PJ, Mazumdar M, Polsky D, et al. Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival. Cancer. 2011;117:1711–20.PubMedCrossRefPubMedCentral
5.
Daryanani D, Plukker JT, de Jong MA, Haaxma-Reiche H, Nap R, Kuiper H, et al. Increased incidence of brain metastases in cutaneous head and neck melanoma. Melanoma Res. 2005;15:119–24.PubMedCrossRef
6.
Sampson JH, Carter JH Jr, Friedman AH, Seigler HF. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg. 1998;88:11–20.PubMedCrossRef
7.
Fife KM, Colman MH, Stevens GN, Firth IC, Moon D, Shannon KF, et al. Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol. 2004;22:1293–300.PubMedCrossRef
8.
Barth A, Wanek LA, Morton DL. Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg. 1995;181:193–201.PubMed
9.
Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199–206.PubMedCrossRefPubMedCentral
10.
Leong SP, Accortt NA, Essner R, Ross M, Gershenwald JE, Pockaj B, et al. Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients. Arch Otolaryngol Head Neck Surg. 2006;132:370–3.PubMedCrossRef
11.
12.
Ozao-Choy J, Hiles JM, Yoon JL, Sim MS, Faries MB, Morton DL. Scalp melanoma: responsible for the poor prognosis of head and neck melanoma? Ann Surg Oncol. 2012;19:S23–4.
13.
Hoersch B, Leiter U, Garbe C. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma. Br J Dermatol. 2006;155:771–7.PubMedCrossRef
14.
Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622–34.PubMed
15.
Richard MA, Grob JJ, Avril MF, Thirion X, Wolkenstein P, Souteyrand P, et al. Melanoma and tumor thickness: challenges of early diagnosis. Arch Dermatol. 1999;135:269–74.PubMed
16.
Garbe C, Buttner P, Bertz J, Burg G, d’Hoedt B, Drepper H, et al. Primary cutaneous melanoma: prognostic classification of anatomic location. Cancer. 1995;75:2492–8.PubMedCrossRef
17.
Gillgren P, Brattstrom G, Frisell J, Persson JO, Ringborg U, Hansson J. Effect of primary site on prognosis in patients with cutaneous malignant melanoma: a study using a new model to analyse anatomical locations. Melanoma Res. 2005;15:125–32.PubMedCrossRef
18.
Fogarty G, Morton RL, Vardy J, Nowak AK, Mandel C, Peta M Forder, et al. Whole brain radiotherapy after local treatment of brain metastases in melanoma patients: a randomised phase III trial. BMC Cancer. 2011;11:142.PubMedCrossRefPubMedCentral
19.
Wronski M, Arbit E. Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients. J Neurosurg. 2000;93:9–18.PubMedCrossRef
20.
Lebbe C, McDermott DF, Robert C. Ipilimumab improves survival in previously treated, advanced melanoma patients with poor prognostic factors: subgroup analysis from a phase III trial. 35th ESMO Congress; 8–12 Oct 2010; Milan.
21.
Thompson JF, Hong A, Fogarty G. Publication and interpretation of clinical trial results: the need for caution. Ann Surg Oncol. 2012;19:1745–7.PubMedCrossRef
22.
Long GV, Kefford RF, Carr PJA. Phase 1/2 study of GSK2118436, a selective inhibitor of V600 mutation (mut) BRAF kinase: evidence of activity in melanoma brain metastases (mets). 35th ESMO Congress; 8–12 Oct 2010; Milan.
23.
Lyle M, Long GV. The role of systemic therapies in the management of melanoma brain metastases. Curr Opin Oncol. 2014;26:222–9.PubMedCrossRef
Metadata
Title
Primary Melanoma Location on the Scalp is an Important Risk Factor for Brain Metastasis: A Study of 1,687 Patients with Cutaneous Head and Neck Melanomas
Authors
Anna M. Huismans, MD
Lauren E. Haydu, BSCHE, MIPH
Kerwin F. Shannon, MBBS
Michael J. Quinn, MBBS
Robyn P. M. Saw, MS
Andrew J. Spillane, MD
Jonathan R. Stretch, MBBS, DPhil
John F. Thompson, MD
Publication date
01-11-2014
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 12/2014
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-3829-9

Other articles of this Issue 12/2014

Annals of Surgical Oncology 12/2014 Go to the issue

Pancreatic Tumors

Long-term Survival After Pancreatic Resection for Renal Cell Carcinoma Metastasis

Breast Oncology

Characterization and Treatment of Local Recurrence Following Breast Conservation for Ductal Carcinoma In Situ

Gynecologic Oncology

Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience

Hepatobiliary Tumors

Pure Laparoscopic Right Hepatectomy with␣the␣Hanging Maneuver for␣Multiple Hepatocellular Adenomas

Breast Oncology

Breast Radiotherapy (RT) Using Tangential Fields (TgF): A Prospective Evaluation of the Dose Distribution in the Sentinel Lymph Node (SLN) Area as Determined Intraoperatively by Clip Placement

Gastrointestinal Oncology

Does Obesity Affect Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Disseminated Mucinous Appendiceal Neoplasms?